Jörn C Albring
5PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 22, 2025
Immune reconstitution in AML and MDS patients undergoing allogeneic hematopoietic cell transplantation (allo-HCT) with treosulfan- or TBI-based conditioning.Lina Kolloch, Philipp Berning, Jörn C Albring
|May 03, 2024
Comparable outcomes for TBI-based versus treosulfan based conditioning prior to allogeneic hematopoietic stem cell transplantation in AML and MDS patients.Philipp Berning, Lina Kolloch, Christian Reicherts
|Jan 10, 2024
Comparison of antibody-based immunotherapeutics for malignant hematological disease in an experimental murine model.Karin Frebel, Jörn C Albring, Anika Wohlgemuth
|Jan 06, 2023
Ibrutinib for First-Line Treatment of Chronic Graft-Versus-Host Disease: Results From the Randomized Phase III iNTEGRATE Study.David Bernard Miklos, Mohammad Abu Zaid, Julian P Cooney
|Jun 11, 2020
First-In-Class CD13-Targeted Tissue Factor tTF-NGR in Patients with Recurrent or Refractory Malignant Tumors: Results of a Phase I Dose-Escalation Study.Christoph Schliemann, Mirjam Gerwing, Hauke Heinzow
Pageof 1
Frequent Collaborators
3 joint publications
Matthias Stelljes
2 joint publications
Philipp Berning
2 joint publications
Christoph Schliemann
2 joint publications
Georg Lenz
1 joint publications
Hauke Heinzow
1 joint publications
Christian Schwöppe
1 joint publications
Moritz Wildgruber
1 joint publications
Linus Angenendt
1 joint publications
Andrew F Berdel
1 joint publications
Björna Berning
